Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinomaGiuseppe Rosiello, Umberto Capitanio, Francesco Cei et al.|Urologic Oncology Seminars and Original Investigations|2022Cited by 41
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most?Giuseppe Fallara, Umberto Capitanio, Alessandro Larcher et al.|World Journal of Urology|2022Cited by 8
Differential Prognostic Value of Extrarenal Involvement in Patients With Non-Metastatic Renal Cell CancerGiacomo Musso, Umberto Capitanio, Giuseppe Fallara et al.|Clinical Genitourinary Cancer|2023Cited by 3